display
The Netherlands is suspending AstraZeneca vaccinations due to concerns about bleeding disorders.
The government announced that the precautionary measure will apply until at least March 29th.
Denmark, Norway and Ireland, among others, had previously announced a temporary stop to vaccinations.
For its part, AstraZeneca emphasizes that there is no increased risk of blood clots in connection with the corona vaccine.
A careful analysis of all available safety data on more than 17 million people in the European Union and the UK who were vaccinated with this vaccine showed no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or low platelet counts (thrombocytopenia) , explains the Swedish-British group.
Parliamentary elections will take place in the Netherlands on Monday.
Over the weekend, thousands demonstrated against the lockdown in The Hague.
The police used water cannons and batons against demonstrators after they disregarded distance rules and calls to break up the rally.
According to media reports, there were several arrests.
Denmark and Norway: reports of blood clots
display
The Danish government also announced last week that it would suspend vaccinations with AstraZeneca's corona vaccine.
As the Danish health authority announced on Thursday, it has received reports of "severe cases of blood clots" in vaccinated people.
So far, however, it has not yet been conclusively clarified whether there is a connection between the vaccinations and the coagulation disorders.
In Norway, it became known over the weekend that three people were being treated for blood clots in hospital after their vaccination.
According to the national health authority, these are health workers, all of them under 50 years of age.
According to the authorities, it is unclear whether there is a connection with the vaccination.
The European Medicines Agency (EMA) will investigate the three cases.
Norway recently stopped issuing the vaccine.
Denmark and Iceland took similar steps shortly afterwards.
display
On Sunday, the vaccination commission in Ireland had spoken out in favor of suspending vaccinations with the preparation until reports from Norway of four cases of severe blood clots after administration of the agent had been examined.
However, the European Medicines Agency (EMA) stated that there was no noticeable accumulation of thromboses in the temporal connection with the vaccination and that the benefits of administering the Astrazeneca agent were greater than the risks.
Austria withdraws batch from traffic
Austria stopped the vaccination of a certain AstraZeneca batch last week after a 49-year-old nurse at the Zwettl State Hospital died as a result of severe coagulation disorders.
A similar death is said to have occurred in Italy.
The infectiologist Clemens Wendtner from the Munich Clinic Schwabing pointed out to the Austrian media that there was no proven connection between the vaccine and the deaths.
"Instead of a causality, a coincidence should be assumed, that is, more coincidence than cause," said Wendtner.
This is also supported by a look at Great Britain: "With more than 22 million vaccinated people, most of whom were vaccinated with AstraZeneca, no relevant safety concerns have yet been expressed on the basis of very good reporting."